Pair Name | Vitamin C, Cimetidine | ||
Phytochemical Name | Vitamin C (PubChem CID: 54670067 ) | ||
Anticancer drug Name | Cimetidine (PubChem CID: 2756 ) | ||
Structure of Phytochemical |
Download
2D
MOL
3D
MOL
|
||
Structure of Anticancer Drug |
Download
2D
MOL
3D
MOL
|
Pair Name | Vitamin C, Cimetidine | |||
Disease Info | [ICD-11: 2C60] | Breast cancer | Investigative | |
Biological Phenomena | Inhibition-->Angiogenesis | |||
Gene Regulation | Down-regulation | Phosphorylation | AKT1 | hsa207 |
Up-regulation | Expression | CASP3 | hsa836 | |
Down-regulation | Phosphorylation | MTOR | hsa2475 | |
Down-regulation | Phosphorylation | PIK3CA | hsa5290 | |
In Vitro Model | MCF-7 | Invasive breast carcinoma of no special type | Homo sapiens (Human) | CVCL_0031 |
In Vivo Model | Each mouse in the experimental group received 0.2 mL EAC saline solution (2.5×10⁶ cells) subcutaneously in the mammary fat pad on day 0. Mice were left for 9 days with free access to water and food to develop solid breast cancer. | |||
Result | We concluded that the synergistic combination provided a promising anti-neoplastic effect via reducing the angiogenesis, oxidative stress, increasing apoptosis,as well as inhibiting the activation of PI3K/AKT/mTOR cue, and suggesting its use as a treatment option for breast cancer. |
No. | Title | Href |
---|---|---|
1 | Anti-neoplastic action of Cimetidine/Vitamin C on histamine and the PI3K/AKT/mTOR pathway in Ehrlich breast cancer. Sci Rep. 2022;12(1):11514. Published 2022 Jul 7. doi:10.1038/s41598-022-15551-6 | Click |